acuteadditionadenocarcinomaadjuvantadultsadvancedadversealkamlamonganalysisannualanotherarticleascoassessmentassociatedautologousbasedbetterbevacizumabbiologybiomarkerbiopsybrafbrainbrca1breastcancercancerscarcinomacardiaccarecellcetuximabchemoradiationchemotherapychildhoodchildrencoloncolorectalcombinationdatadecisiondetectiondiagnoseddiffusediscussiondiseasedondosedoubledrearlyefficacyegfrendendometrialevolutionfinancialfirstfollicularfollowfollowinggastricgermlinehematopoieticher2highhithodgkinhormonehoursiiiiiimagingimmuneimpactimplicationsimportanceimproveimprovesinducedinhibitioninhibitorinsightsinvasivelargelateleukemialifelikelinelocallylonglowlunglymphoblasticlymphomalymphomasmaintenancemanagementmedicalmedicaremeetingmelanomametastasesmetastaticminimalmolecularmortalitymrdmultimultiplemutantmutatedmutationmutationsmyeloidmyelomanegativeneoadjuvantnivolumabnovelnsclcolderoptionsoutcomeoutcomesovarianpancreaticpatientpatientspediatricpembrolizumabphasepluspositiveprimaryprimeprognosticpromiseprostatequalityquestionradiationradiotherapyrarereadyreceivingreceptorrectalrecurrencerecurrentrefractoryrelapsedrelatedresearchresectableresidualresponseresultsriskrituximabrolesafetyscreeningsecondsequencingsettingsinglesmallsmokingstagestemstudysurgerysurvivalsurvivorssystemictermtestingtherapeutictherapytimetoxicitytransplanttransplantationtrastuzumabtreatedtreatmenttrialtrialstumortumorsuseusingvalueversuswomen